Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
46.48
+0.41 (0.89%)
At close: Dec 5, 2025, 4:00 PM EST
46.50
+0.02 (0.04%)
After-hours: Dec 5, 2025, 6:27 PM EST
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $6.08 billion as of December 5, 2025. Its market cap has decreased by -43.56% in one year.
Market Cap
6.08B
Enterprise Value
4.46B
1-Year Change
-43.56%
Ranking
Category
Stock Price
$46.48
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $6.08B, an increase of 340.92%. That is a compound annual growth rate of 31.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 6.03B | -40.89% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |